Investors Overview

The Company is publicly traded on the Toronto Stock Exchange under the symbol MRV and in the U.S. on the OTCQX market under the symbol MRVFF






Profile


Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. Miravo’s head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the manufacturing facility is located in Varennes, Québec, Canada.


Latest Annual Report


2020

March 8, 2021



Stock Snapshot



Why Invest in Miravo


Organic growth from existing products and short-term new product launches

Significant adjusted total revenue and adjusted
EBITDA

Cash generated from operations

Key growth products – Blexten, Cambia and Suvexx continue to gain market share

Internal team and infrastructure can support significant growth

Key product portfolio protected by IP and long-term partner relationships

To receive press releases via email, provide your address below.
Click here to unsubscribe.

  • This field is for validation purposes and should be left unchanged.